Artemether
12-B-dihydro artemisinin methyl ether. (Chemical formula not provided)
Schizontocidal drug that inhibits protein synthesis during trophozoite growth.
Intramuscular injection
Dosage for children varies based on age and weight. Adults receive 160mg (in divided doses) initially followed by 80mg daily from the 2nd to 5th day.
Treatment of severe and complicated malaria in adults and children.
Hypersensitivity to artemether or artemisinin compounds. Not recommended in the first trimester of pregnancy.
Do not exceed the prescribed dose. Warm the ampoule before use if frozen. Use with caution in patients with cardiovascular disease, hepatic impairment, or renal insufficiency.
Three years
Manufactured by Tianjin Kingyork Group Hubei Tianyao Pharmaceutical Co., Ltd. and marketed by Pemason Pharmaceuticals Ltd.
A4-6573